Roche is a leading healthcare company that has for over 100 years been active in the discovery, development, manufacture and marketing of healthcare solutions. Our products and services address prevention diagnosis and treatment of diseases, thus enhancing well-being and quality of life.

Tanner Industries is a family owned and operated distributor of anhydrous and aqua ammonia.

Gelest, Inc., headquartered in Morrisville, PA, USA, was founded in 1991 to serve the advanced technology applications markets and is recognized worldwide as an innovator, manufacturer and supplier of Organo-Silicon and Metal-Organic materials for commercial production and R&D support. Since its inception, Gelest, Inc. has continuously added experts in the fields of silanes, silicones, and metal-organics. The technical staff includes individuals with extensive hands-on experience and academic credentials (see Management Team). Joint developments between customers and staff have led to an increased product offering from several hundred materials to the current listing of several thousand materials. The company has focused its research and development efforts toward expanding the offering of Group 4A and 4B analogs. Gelest, Inc. offers the most comprehensive selection of silane, silicone, and metal-organic materials in the world

Every day 30 million people benefit from Kuehne Company’s water treatment products. Since 1919, our family-owned company has delivered the reliability and quality that our customers need and trust. We are all about people and our planet, and from our truck drivers to our scientists, everything we do is focused on safety, efficiency, quality, health and environmental sustainability. Our voice is active in the national institutes that govern our industry, and we continue to strive for a better, clearer (planet) future.

Grant Industries engages in the research, development, manufacturing, and marketing of textile, cosmetic, and performance specialty chemicals. We serve all major global cosmetic markets and are known for our award-winning products, cutting-edge research and personalized customer care. Our dedication to product performance and customer support makes us the ideal source for state-of-the-art ingredients to improve your product's skin feel. Our main product categories include: polysilicone-11 elastomer gels, silicone/active powders, microsphere powders, surfactants, UV dispersions, specialty silicone fluids and formulated cosmetic ingredients. Additional information on the company and its products are available on the web site grantinc.com Technical Support? [email protected]

Polysciences, Inc. is a manufacturer of fine and specialty chemical materials for industrial, consumer, academic research and biotechnology applications. For six decades Polysciences, Inc. has developed and manufactured a wide range of products for customers working within the life sciences, histology, microsopy, immunology, monomer and polymer, microparticles, electronic chemicals and personal care markets.

J-STAR Research, Inc. is a contract chemistry organization serving as an outsourcing partner for the pharmaceutical and biotechnology industries. J-STAR is a leading provider of services in organic synthesis problem solving, early phase non-GMP and GMP manufacturing and crystallization R&D. While high quality synthetic chemistry and process research services continue to be J-Star’s foundation, the company has steadily added and continues to expand in the areas of QC, GMP and QA, Crystallization R&D, Solid Form and Polymorph Screening, Catalysis Screening + Enabling Technology, Highly Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation by NMR and HR-LC/MS and Preformulation for Drug Product Development. J-Star’s expert team of scientists and professionals coupled with solid industrial experience, a track record of dependability, and over 70,000 SF of well-equipped laboratories across two New Jersey research facilities ensures that all projects are delivered in full, on time and with rigorous quality.

Family owned and operated since 1840, Palmer’s is one of the longest standing proprietors of skin and hair care products in the world. Our commitment to quality has made Palmer’s a trusted household name, used by families for generations. We are committed to choosing what’s real, using natural, raw ingredients in our products. As members of the World Cocoa Foundation and Global Shea Alliance, Palmer’s helps empower farmers & communities to create and promote healthy, sustainable production from farm to bottle.

Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.

We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System™ (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or older. XHANCE was made widely available through commercial channels in April 2018. In March and June 2022, we announced positive top line results from our two Phase 3b clinical trials (ReOpen1 and ReOpen2) of XHANCE for a follow-on indication for the treatment of chronic sinusitis. In February 2023, we submitted a prior approval efficacy supplement (sNDA) to support the approval of a new indication for XHANCE for the treatment of chronic rhinosinusitis. If the sNDA is approved, XHANCE has the potential to be the first drug therapy approved by the FDA for the treatment of chronic sinusitis. As of February 20, 2023, we had a total of 141 full-time employees all of whom are in the United States, and no part-time employees. Culture is a critical element in the management of our organization. Our colleagues are focused on driving our business with the Optinose values as the foundation for all our efforts. Our goal is that each colleague feels a deep connection to what they do, loves coming to work and is aligned to our One Mission – to improve lives. Our values of Authenticity, Fearless Conversations, Friendship, Openness, Perseverance and Possibility Thinking guide our actions and decisions.

ResinTech Inc., an acknowledged leader in ion exchange, manufactures a broad range of ion exchange resins for water and waste water treatment, including deionization,softening, metals removal, product purification, resource recovery, and pollution control. In addition to its ion exchange resins, ResinTech supplies activated carbon and inorganic selective exchangers. ResinTech has developed an application technology resource group that includes state-of-the-art laboratories and a group of scientists dedicated to expanding the frontiers of application technology. This group is put to use whenever product or process recommendations are requested, assuring customers get the most cost-effective approach to achieving their process goals.